(Q52872238)
Statements
First-in-human phase I study of the liposomal RNA interference therapeutic Atu027 in patients with advanced solid tumors (English)
Beate Schultheis
Dirk Strumberg
Ansgar Santel
Christiane Vank
Frank Gebhardt
Oliver Keil
Christian Lange
Klaus Giese
Jörg Kaufmann
17 November 2014